STUART COWLEY: Open Payments
NPI 1811429756 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,134 in 54 payments from 10 companies in 2025. Trend: 2023 $3,527 · 2024 $1,711 · 2025 $6,134
Food & beverage: $3,767Travel & lodging: $2,367
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 25 | $3,562 |
| Globus Medical, Inc. | 9 | $875 |
| Boston Scientific Corporation | 8 | $854 |
| SI-BONE, INC. | 2 | $290 |
| MML US, Inc. | 1 | $133 |
| SPR Therapeutics, Inc | 2 | $130 |
| TerSera Therapeutics LLC | 1 | $124 |
| DePuy Synthes Sales Inc. | 3 | $87 |
| Medtronic, Inc. | 2 | $63 |
| Amgen Inc. | 1 | $15 |
Products named: PROCLAIM, Vyrsa V1, ETERNA, General - Pain Management, Senza, Clinical Trial Product, ReActiv8, SPRINT PNS System.
Industry payments across KY — which companies pay providers there.
